Topic: Epogen
Reuters US Online Report Health News | 2010-03-02 20:45:06
CHICAGO (Reuters) - Aggressive treatment with blockbuster anemia drugs may offer the best approach for kidney dialysis patients with severe anemia, U.S. researchers said on Tuesday. But aggressive treatment only made things worse for patients in the final stages of kidney disease with mild anemia, they reported in the Journal of the American Medical Association. The findings may help guide ...
AP News | 2010-01-25 22:16:20
<div id="subtitle">Amgen reports mixed 4Q results for anemia drugs but says revenue from other drugs was stable</div><div><p>Biotechnology company Amgen Inc. said Monday its profit rose 1 percent in the fourth quarter, as the company reported mixed results for its anemia drugs, but said sales of its ...
AP News | 2010-01-08 15:34:39
<div id="subtitle">Amgen shares fall as FDA officials urge dosing studies for anemia drugs in kidney patients</div><div><p>Shares of Amgen Inc. fell Thursday over concerns that the Food and Drug Administration's plan to re-examine the safety of anemia drugs could pressure sales of leading anemia treatments Aranesp ...
AP News | 2009-12-22 22:40:10
<div id="subtitle">Amgen says US District Court upholds ruling that blocks Roche from selling Mircera until 2014</div><div><p>Swiss drugmaker Roche will not be allowed to sell its anemia drug Mircera in the U.S. until July 2014 under terms of a settlement with Amgen Inc., the companies said ...
1
2
